Recent studies have shown that inflammatory signaling pathways are involved in carcinogenesis via activation of NF-κB signaling (Sun et al., 2019), which may act as a downstream pathway regulating BC proliferation and progression (Xu Jing et al., 2020). The gene discussed is NFKB1; the disease is breast cancer.